Whitehawk Therapeutics, Inc. Common Stock (WHWK) Stock Price

WHWKStock

$2.89+10.73%52W

Market Cap$164.76M

P/E—

PEG Ratio—

Div yield—

Beta1.00

WHWK Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-37.66%

Price vs S&P 500 (4W)-27.14%

VGM Score30.14

Book Value / Share (Quarterly)$3.21

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-22.28%

Cash Flow / Share (Quarterly)$-1.22

Price vs S&P 500 (YTD)7.49%

Gross Margin (TTM)88.72%

Net Profit Margin (TTM)99.42%

EPS (TTM)$-3.03

10-Day Avg Trading Volume0.36M

EPS Excl Extra (TTM)$-3.03

Revenue Growth (5Y)-13.79%

EPS (Annual)$-0.44

ROI (Annual)-15.11%

Gross Margin (Annual)89.36%

Net Profit Margin (5Y Avg)-2206.09%

Cash / Share (Quarterly)$3.33

ROA (Last FY)-13.66%

Revenue Growth TTM (YoY)-72.50%

EBITD / Share (TTM)$-1.49

ROE (5Y Avg)-63.58%

Operating Margin (TTM)87.41%

Cash Flow / Share (Annual)$-2.08

P/B Ratio0.99x

P/B Ratio (Quarterly)1.35x

Net Income / Employee (Annual)$-895,500

Net Interest Coverage (TTM)-193.55x

ROA (TTM)-49.97%

EPS Incl Extra (Annual)$-0.44

Current Ratio (Annual)10.26x

Quick Ratio (Quarterly)17.16x

3-Month Avg Trading Volume0.43M

52-Week Price Return10.73%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)25.31x

Asset Turnover (Annual)0.05x

52-Week High$5.50

Operating Margin (5Y Avg)-2251.81%

EPS Excl Extra (Annual)$-0.44

CapEx CAGR (5Y)94.17%

26-Week Price Return-27.75%

Quick Ratio (Annual)10.03x

13-Week Price Return-25.71%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)17.38x

Enterprise Value$95.58M

Revenue / Share Growth (5Y)-50.84%

Asset Turnover (TTM)0.23x

Revenue / Employee (Annual)$310,700

Inventory Turnover (Annual)0.29x

Pretax Margin (Annual)-288.26%

Cash / Share (Annual)$3.09

3-Month Return Std Dev57.34%

Net Income / Employee (TTM)$-3,470,900

ROE (Last FY)-15.11%

Net Interest Coverage (Annual)-330.67x

EPS Basic Excl Extra (Annual)$-0.44

Receivables Turnover (TTM)2.42x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-3.03

Receivables Turnover (Annual)2.42x

ROI (TTM)-53.89%

P/S Ratio (TTM)6.51x

Pretax Margin (5Y Avg)-2206.09%

Revenue / Share (Annual)$0.15

Price vs S&P 500 (52W)-4.80%

Year-to-Date Return19.42%

5-Day Price Return-14.50%

EPS Normalized (Annual)$-0.44

ROA (5Y Avg)-51.29%

Net Profit Margin (Annual)-288.26%

Month-to-Date Return-23.14%

EBITD / Share (Annual)$-0.57

Operating Margin (Annual)-379.76%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-62.90%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-3.03

P/B Ratio (Annual)0.84x

Inventory Turnover (TTM)0.29x

Pretax Margin (TTM)99.42%

Book Value / Share (Annual)$2.89

Price vs S&P 500 (13W)-28.39%

Beta1.00x

Revenue / Share (TTM)$0.00

ROE (TTM)-53.89%

52-Week Low$1.97

gGradeF

mGradeC

vgmGradeD

WHWK Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.26	-$0.20	+23.08%(+$0.06)
Q1 2026	May 7, 2026	-$0.33	-$0.32	+2.04%(+$0.01)
Q4 2025	Mar 12, 2026	-$0.27	-$0.34	-25.93%(-$0.07)
Q3 2025	Nov 6, 2025	-$0.22	-$0.25	-15.40%(-$0.03)
Q2 2025	Aug 7, 2025	-$0.17	-$0.76	-347.06%(-$0.59)

WHWK Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

3.92

4.00

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
WHWKWhitehawk Therapeutics, Inc. Common Stock	—	F	C	6.5x	-72.5%	88.7%	—	$2.89
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Whitehawk Therapeutics, Inc. Common Stock

Whitehawk Therapeutics is a preclinical-stage oncology company developing next-generation antibody-drug conjugates for difficult-to-treat cancers. Its three-asset ADC portfolio is engineered to overcome first-generation limitations and improve therapeutic efficacy.

WHWK Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$0.24

Revenue estimate$0

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

LTBRLightbridge Corp.Industrial Chemicals
IVVDInvivyd, Inc. Common StockBiological Products
STROSutro Biopharma, Inc.Biological Products
ACOGAlpha Cognition Inc. Common StockBiological Products
IPHAInnate Pharma S.A. ADSBiological Products
DTILPrecision BioSciences, Inc. Common StockBiological Products
CMPXCompass Therapeutics, Inc. Common StockBiological Products
MDWDMediWound Ltd.Pharmaceutical Preparations

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.0

Buy

Consensus rating

52-Week Range

Low$1.97

High$5.50